A62 TREATMENT OF TUBERCULOSIS: Clinical Profiles Of Linezolid Resistant Tuberculosis Cases In Mumbai

Methods: At the Hinduja Hospital, a private tertiary medical centre with a referral bias towards non responders and an accredited Mycobacteriology laboratory, Mycobacterium tuberculosis ^ТВ) isolates were tested for susceptibility to 14 drugs using Mycobacterium Growth Indicator Tube - MGH" 960...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 195
Main Authors Ganatra, S R, Udwadia, Z F, Mullerpattan, J B, Banka, R A, Sharma, U, Kambli, P G, Rodrigues, C S
Format Journal Article
LanguageEnglish
Published New York American Thoracic Society 01.01.2017
Subjects
Drugs
Tuberculosis
India
Online AccessGet full text

Cover

More Information
Summary:Methods: At the Hinduja Hospital, a private tertiary medical centre with a referral bias towards non responders and an accredited Mycobacteriology laboratory, Mycobacterium tuberculosis ^ТВ) isolates were tested for susceptibility to 14 drugs using Mycobacterium Growth Indicator Tube - MGH" 960 fåD Diagnostics) at the WHO recommended DST Critical Concentrations. For linezolid, a Critical Concentration of 1.0 mcg/ml was used. Since July 2015, 2173 isolates have undergone drug susceptibility testing to 14 drugs including linezolid.
ISSN:1073-449X
1535-4970